enVVeno Medical (NVNO) Non Operating Investment Income (2022 - 2026)
enVVeno Medical (NVNO) posted quarterly Non Operating Investment Income of $209000.0 for Q2 2026, down 12.55% year-over-year from $239000.0 in Q2 2025, and down 12.18% quarter-over-quarter from $238000.0 in Q1 2026.
enVVeno Medical (NVNO) Non Operating Investment Income (2022 - 2026) Analysis & Trends
enVVeno Medical's Non Operating Investment Income history runs 5 years deep, the most recent figure standing at $209000.0 for Q2 2026.
- In Q2 2026, Non Operating Investment Income fell 12.55% year-over-year to $209000.0; the TTM figure through Jun 2026 stood at $908000.0 (down 40.18% YoY), while the FY2025 annual figure was $1.1 million, down 31.34% from the prior year.
- Non Operating Investment Income for Q2 2026 stood at $209000.0, down from $238000.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $676000.0 in Q4 2023, with the low at -$113000.0 in Q2 2022.
- The 5-year median for Non Operating Investment Income is $238000.0 (2026), against an average of $255294.1.
- The sharpest annual moves came in 2023 and 2025: Non Operating Investment Income jumped 804.76% in 2023, then tumbled 51.4% in 2025.
- enVVeno Medical's Non Operating Investment Income stood at $187000.0 in 2022, then soared by 261.5% to $676000.0 in 2023, then tumbled by 37.13% to $425000.0 in 2024, then tumbled by 40.47% to $253000.0 in 2025, then decreased by 17.39% to $209000.0 in 2026.
- Business Quant data shows NVNO's Non Operating Investment Income at $209000.0 in Q2 2026, $238000.0 in Q1 2026, and $253000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | - |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | - |
| 10 | enVVeno Medical | 7.05 Mn | 7.05 Mn | - | 209,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 209,000.00 |
| Jun 30, 2026 | 209,000.00 |
| Mar 31, 2026 | 238,000.00 |
| Mar 31, 2026 | 238,000.00 |
| Dec 31, 2025 | -1.26 Mn |
| Dec 31, 2025 | -1.26 Mn |
| Sep 30, 2025 | -39,000.00 |
| Sep 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -79,000.00 |
| Jun 30, 2025 | -79,000.00 |
| Mar 31, 2025 | -194,000.00 |
| Mar 31, 2025 | -194,000.00 |
| Dec 31, 2024 | 425,000.00 |
| Dec 31, 2024 | 425,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | 408,000.00 |
| Mar 31, 2024 | 408,000.00 |